Accessibility Menu
Creo Medical Group Plc logo

Creo Medical Group Plc

(LSE) CREO

Current Price£0.13
Market Cap£61.08M
Since IPO (2016)-83%
5 Year-94%
1 Year-15%
1 Month+9%

Creo Medical Group Plc Financials at a Glance

Market Cap

£61.08M

Revenue (TTM)

£36.30M

Net Income (TTM)

-£17.10M

EPS (TTM)

£0.01

P/E Ratio

10.62

Dividend

£0.00

Beta (Volatility)

0.00 (Low)

Price

£0.13

Volume

1,223,872

Open

£0.13

Previous Close

£0.13

Daily Range

£0.13 - £0.14

52-Week Range

£0.10 - £0.19

Estimated Earnings Date

Sep 30, 2026

CREO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Creo Medical Group Plc

Industry

Healthcare Equipment and Supplies

Employees

109

CEO

Craig Jonathan Gulliford

Headquarters

Chepstow, NP16 5UH, GB

CREO Financials

Key Financial Metrics (TTM)

Gross Margin

32%

Operating Margin

-3%

Net Income Margin

88%

Return on Equity

0%

Return on Capital

-40%

Return on Assets

9%

Earnings Yield

9.42%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£61.08M

Shares Outstanding

449.14M

Volume

1.22M

Avg. Volume

723.65K

Financials (TTM)

Gross Profit

£1.40M

Operating Income

-£20.70M

EBITDA

-£19.70M

Operating Cash Flow

-£18.60M

Capital Expenditure

£0.00

Free Cash Flow

-£18.60M

Cash & ST Invst.

£12.40M

Total Debt

£4.10M

Creo Medical Group Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£3.80M

-75.8%

Gross Profit

£900.00K

-84.5%

Gross Margin

23.68%

N/A

Market Cap

£61.08M

N/A

Market Cap/Employee

£219.72K

N/A

Employees

278

N/A

Net Income

-£11.60M

+0.0%

EBITDA

-£10.20M

+10.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£12.40M

-33.0%

Total Debt

£4.10M

-50.6%

Accounts Receivable

£6.90M

-12.7%

Inventory

£2.50M

-69.1%

Long Term Debt

£1.80M

-65.4%

Short Term Debt

£2.30M

-25.8%

Return on Assets

8.97%

N/A

Return on Invested Capital

-39.96%

N/A

Free Cash Flow

-£34.20M

-375.0%

Operating Cash Flow

-£34.20M

-434.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SPEC.LINSPECS Group plc
£0.85+0.00%
KOO.LKooth plc
£1.68+0.30%
HVO.LhVIVO plc
£0.09-2.79%
HEMO.LHemogenyx Pharmaceuticals Plc
£7.65-4.44%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$29.27-0.28%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.25+0.06%
DSYBig Tree Cloud
$7.20+2.91%
TQQQProShares Trust - ProShares UltraPro Qqq
$69.27-0.06%

Questions About CREO

What is the current price of Creo Medical Group Plc?

Creo Medical Group Plc is trading at £0.13 per share.

What is the 52-week range for Creo Medical Group Plc?

Over the past 52 weeks, Creo Medical Group Plc has traded between £0.10 and £0.19.

How much debt does Creo Medical Group Plc have?

As of the most recent reporting period, Creo Medical Group Plc reported total debt of £4.10M.

How much cash does Creo Medical Group Plc have on hand?

Creo Medical Group Plc reported £12.40M in cash and cash equivalents in its most recent financial results.

What is Creo Medical Group Plc’s dividend yield?

Creo Medical Group Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.